September 2026
The global anti jamming GPS market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 7.35 billion by 2035, growing at a CAGR of 5.38%.
September 2026
The biosimilar monoclonal antibody market was valued at USD 19.73 billion in 2026, with leading companies including Roche, Mylan, Biogen.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The respiratory antiviral treatment market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global anti-money laundering software market size is projected to hit around USD 10.74 billion by 2035 from USD 4.27 billion in 2026 with a CAGR of 10.83%.
September 2026
The global antibody discovery market size was estimated at USD 9.92 billion in 2026 and is projected to hit around USD 22.28 billion by 2035 with a CAGR of 9.42%.
September 2026
The global antioxidants market size is calculated at USD 4.67 billion in 2026 and is projected to hit around USD 8.38 billion by 2035, with a CAGR of 6.73%.
September 2026
The global food antioxidants market size is calculated at USD 2.53 billion in 2026 and is projected to hit around USD 4.37 billion by 2035 with a CAGR of 6.27%.
September 2026
The global anti-D immunoglobulin market size is estimated to hit around USD 5.85 billion by 2035 increasing from USD 3.61 billion in 2026, with a CAGR of 5.51%.
September 2026
The global anti-snoring devices market size was evaluated at USD 1.34 billion in 2026 and is predicted to hit around USD 2.94 billion by 2035, growing at a CAGR of 9.12%.
September 2026
The global skin antiseptic products market size is calculated at USD 3.90 billion in 2026 and is projected to hit around USD 6.85 billion by 2035 with a CAGR of 6.5%.
September 2026
The antiscalants market size reached USD 4.68 billion in 2026, with leading antiscalants market companies including Clariant AG, Kemira Oyj, General Electric, Dow Chemicals.
September 2026
The global anti-obesity drugs market size is estimated at USD 8.96 billion in 2026, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
September 2026
The global anti-corrosion coatings market size is valued at USD 38.34 billion in 2026 and is projected to hit around USD 62.32 billion by 2035 with a CAGR of 5.55%.
September 2026
The global antidepressant drugs market size was evaluated at USD 20.09 billion in 2026 and is projected to cross around USD 26.06 billion by 2034, with a CAGR of 3.22%.
September 2026
The global snake antivenom market size was valued at USD 385.84 billion in 2026 and is expected to reach around USD 686.98 billion by 2034 with a CAGR of 7.43%.
September 2026
The global anti-acne cosmetics market size was calculated at USD 6.30 billion in 2026 and is predicted to attain around USD 12.65 billion by 2034, with a CAGR of 9.11%.
September 2026
The global anti-fatigue mats market size is evaluated at USD 2.09 billion in 2026 and is expected to be worth around 3.09 billion by 2034, with a CAGR of 5.04%.
September 2026
The global veterinary antibiotics market size is projected to hit around USD 7.19 billion by 2034, increasing from USD 5.60 billion in 2026, with a CAGR of 3.18%.
September 2026
The global veterinary analgesics anti inflammatory market size is estimated to hit around USD 4.58 billion by 2034 increasing from USD 2.76 billion in 2026, with a CAGR of 6.54%.
September 2026
The global veterinary antihistamines market size is estimated to hit around USD 2.12 billion by 2034 increasing from USD 1.39 billion in 2026, with a CAGR of 5.43%.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The antimicrobial coatings market size reached USD 16.91 billion in 2026, with leading antimicrobial coatings market companies including Becton, Dickinson and Company (BD), Baxter International, AkzoNobel .
September 2026
The immuno-oncology antibodies market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The anti-snoring treatment market size was estimated at USD 1.82 billion in 2026 and is expected to surpass around USD 3.65 billion by 2035, with a CAGR of 8.07%.
September 2026
The global anti-pollution skincare products market size is calculated at USD 16.30 billion in 2026 and is expected to hit around USD 28.33 billion by 2034, with a CAGR of 7.15%.
September 2026
The antiviral and antimicrobial technology market is growing with demand for advanced coatings, textiles, and surfaces that prevent infection and contamination.
September 2026
The global custom antibody market reached USD 232.14 billion in 2026, featuring leading custom antibody companies such as GenScript, LifeSpan BioSciences, Inc, Labcorp Drug Development, Abmart.
August 2026
The monoclonal antibodies market size totalled USD 321.83 billion in 2026, with major monoclonal antibodies market players including johnson & johnson, merck, AbbVie, amgen, Pfizer inc, norvatis ag.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com